Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases
Executive Summary
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
You may also be interested in...
Canada’s Consumer Health Trade Groups Merge; Survey Shows Pandemic Spurs Self-Care Increase
One group, CHP Canada, also recently published survey results showing more Canadians are turning to self-care during the COVID-19 pandemic. CHP Canada and Food and Consumer Products of Canada merged to create Food, Health & Consumer Products of Canada.
US Consumers Using More Supplements And Higher Doses During Pandemic – CRN Survey
Results of CRN’s survey of supplement users 18 and older point to usage increases continuing after pandemic ends and to market categories VMS providers should target as consumers’ supplementation patterns change.
Curecumin Piques US Consumers’ Interest; UK Curiosity Grows For Omega-3, Survey Shows
Marketing consultant Buzzback surveyed 800 consumers in March, prior to novel coronavirus shutdowns in the two countries, to identify ingredients that offer opportunities for brands in health care, wellness and skin care.